循环RNAs:心力衰竭拼图中的一个小块
Reza Eshraghi1, Davood Shafie2, Arash Raisi1
1Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran.
Functional & integrative genomics
|May 17, 2024
概括
循环RNAs (circRNAs) 显示出作为新的生物标志物和心力衰竭 (HF) 的治疗点的前景. 它们的稳定性,特别是在外体中,使得它们在诊断和治疗心血管疾病方面非常有价值.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 心力衰竭 (HF) 是一种主要的心血管疾病,需要新的治疗方法和生物标志物.
- 像微RNA和长非编码RNA这样的RNA子组被探索为个性化的HF护理.
- 循环RNAs (circRNAs) 正在成为一种潜在的新型HF生物标志物和治疗点.
研究的目的:
- 审查与心力衰竭相关的circRNAs的生物发生和特征.
- 讨论circRNAs在心脏功能中的作用及其作为血液生物标志物的潜力.
- 概述HF和其他心血管疾病中circRNAs的未来研究方向.
主要方法:
- 文献综述侧重于circRNA生物发生,功能和心血管疾病中的临床相关性.
- 对心力衰竭模型和患者样本中的circRNAs现有研究的分析.
- 综合关于外体环RNAs作为生物标志物和治疗剂的信息.
主要成果:
- 循环RNA具有独特的特性,使其适合HF研究.
- 外体环RNAs表现出稳定性,表明其作为可靠生物标志物的潜力.
- 循环RNAs与各种心血管疾病的发病和进展有关,包括高血压.
结论:
- 循环RNA,特别是外体形式,代表了心力衰竭诊断和治疗的前沿.
- 对circRNA机制和临床应用的进一步研究是有必要的.
- 向circRNAs可能为心血管疾病提供新的治疗策略.
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:22Heart Failure Drugs: Diuretics
367
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
367
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
80
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
80